TRPM7 is markedly upregulated in atrial fibrillation (AF) patients, activating the calcineurin pathway and producing a synergistic effect with TGFβ1, and resulting in the activation of fibroblasts. This evidence concerns the gene TGFB1 and atrial fibrillation.